DPHARMA

Quarterly rpt on consolidated results for the financial period ended 31 Mar 2019

DUOPHARMA BIOTECH BERHAD

Financial Year End 31 Dec 2019
Quarter 1 Qtr
Quarterly report for the financial period ended 31 Mar 2019
The figures have not been audited

Attachments

Q12019 Financial Results.pdf
536.4 kB

  • Default Currency
  • Other Currency

Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
31 Mar 2019

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
31 Mar 2019
31 Mar 2018
31 Mar 2019
31 Mar 2018
$$'000
$$'000
$$'000
$$'000
1 Revenue
150,386
133,259
150,386
133,259
2 Profit/(loss) before tax
18,786
13,255
18,786
13,255
3 Profit/(loss) for the period
14,465
10,647
14,465
10,647
4 Profit/(loss) attributable to ordinary equity holders of the parent
14,465
10,647
14,465
10,647
5 Basic earnings/(loss) per share (Subunit)
2.19
1.64
2.19
1.64
6 Proposed/Declared dividend per share (Subunit)
0.00
0.00
0.00
0.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
 Net assets per share attributable to ordinary equity holders of the parent ($$)
0.7500
0.7300

Remarks : 
Pursuant to MFRS 133 (Earnings Per Share), the Earnings Per Share i.e. 1.64 sen, for the corresponding quarter and corresponding period ended 31 March 2018 had been retrospectively adjusted to reflect the effect of the bonus issue.

Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:

Country Base Unit Subunit
Malaysia Ringgit Sen
United States Dollar Cent
United Kingdom Pound Pence



Announcement Info

Company Name DUOPHARMA BIOTECH BERHAD
Stock Name DPHARMA
Date Announced 21 May 2019
Category Financial Results
Reference Number FRA-14052019-00006


View original report